Epix Pharmaceuticals

Epix Pharmaceuticals Inc (formerly Predix Pharmaceuticals Inc) was a pharmaceutical company based in Lexington, Massachusetts.

Its products included the following agents:^{[citation needed]}

• PRX-00023—5-HT_1A receptor full agonist (later discovered to be an antagonist): for major depression and generalized anxiety disorder
• PRX-03140—5-HT₄ receptor partial agonist: for Alzheimer's disease
• PRX-07034—5-HT₆ receptor antagonist: for obesity and cognitive impairment associated with Alzheimer's disease and schizophrenia
• PRX-08066—5-HT_2B receptor antagonist: for pulmonary hypertension associated with chronic obstructive pulmonary disease

As of July 2009, the company was in the process of asset liquidation due to insufficient funds to stay afloat.^[1]

References

External links

• EPIX Pharmaceuticals, Inc. web site

This article about a medical, pharmaceutical or biotechnological corporation or company is a stub. You can help Wikipedia by expanding it.

• v
• t
• e

This page was last edited on 19 October 2023, at 13:56